Cargando…

Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors

New therapies for treating coronaviruses are urgently needed. A series of 4-anilino-6-aminoquinazoline derivatives were synthesized and evaluated to show high anti-MERS-CoV activities. N(4)-(3-Chloro-4-fluorophenyl)-N(6)-(3-methoxybenzyl)quinazoline-4,6-diamine (1) has been identified in a random sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jun Young, Shin, Young Sup, Lee, Jihye, Kwon, Sunoh, Jin, Young-hee, Jang, Min Seong, Kim, Seungtaek, Song, Jong Hwan, Kim, Hyoung Rae, Park, Chul Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414322/
https://www.ncbi.nlm.nih.gov/pubmed/32781216
http://dx.doi.org/10.1016/j.bmcl.2020.127472
_version_ 1783568952563073024
author Lee, Jun Young
Shin, Young Sup
Lee, Jihye
Kwon, Sunoh
Jin, Young-hee
Jang, Min Seong
Kim, Seungtaek
Song, Jong Hwan
Kim, Hyoung Rae
Park, Chul Min
author_facet Lee, Jun Young
Shin, Young Sup
Lee, Jihye
Kwon, Sunoh
Jin, Young-hee
Jang, Min Seong
Kim, Seungtaek
Song, Jong Hwan
Kim, Hyoung Rae
Park, Chul Min
author_sort Lee, Jun Young
collection PubMed
description New therapies for treating coronaviruses are urgently needed. A series of 4-anilino-6-aminoquinazoline derivatives were synthesized and evaluated to show high anti-MERS-CoV activities. N(4)-(3-Chloro-4-fluorophenyl)-N(6)-(3-methoxybenzyl)quinazoline-4,6-diamine (1) has been identified in a random screen as a hit compound for inhibiting MERS-CoV infection. Throughout optimization process, compound 20 was found to exhibit high inhibitory effect (IC(50) = 0.157 μM, SI = 25) with no cytotoxicity and moderate in vivo PK properties.
format Online
Article
Text
id pubmed-7414322
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74143222020-08-10 Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors Lee, Jun Young Shin, Young Sup Lee, Jihye Kwon, Sunoh Jin, Young-hee Jang, Min Seong Kim, Seungtaek Song, Jong Hwan Kim, Hyoung Rae Park, Chul Min Bioorg Med Chem Lett Article New therapies for treating coronaviruses are urgently needed. A series of 4-anilino-6-aminoquinazoline derivatives were synthesized and evaluated to show high anti-MERS-CoV activities. N(4)-(3-Chloro-4-fluorophenyl)-N(6)-(3-methoxybenzyl)quinazoline-4,6-diamine (1) has been identified in a random screen as a hit compound for inhibiting MERS-CoV infection. Throughout optimization process, compound 20 was found to exhibit high inhibitory effect (IC(50) = 0.157 μM, SI = 25) with no cytotoxicity and moderate in vivo PK properties. Elsevier Ltd. 2020-10-15 2020-08-08 /pmc/articles/PMC7414322/ /pubmed/32781216 http://dx.doi.org/10.1016/j.bmcl.2020.127472 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lee, Jun Young
Shin, Young Sup
Lee, Jihye
Kwon, Sunoh
Jin, Young-hee
Jang, Min Seong
Kim, Seungtaek
Song, Jong Hwan
Kim, Hyoung Rae
Park, Chul Min
Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
title Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
title_full Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
title_fullStr Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
title_full_unstemmed Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
title_short Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
title_sort identification of 4-anilino-6-aminoquinazoline derivatives as potential mers-cov inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414322/
https://www.ncbi.nlm.nih.gov/pubmed/32781216
http://dx.doi.org/10.1016/j.bmcl.2020.127472
work_keys_str_mv AT leejunyoung identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT shinyoungsup identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT leejihye identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT kwonsunoh identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT jinyounghee identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT jangminseong identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT kimseungtaek identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT songjonghwan identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT kimhyoungrae identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors
AT parkchulmin identificationof4anilino6aminoquinazolinederivativesaspotentialmerscovinhibitors